Amrutanjan Health Care Limited (NSE:AMRUTANJAN)

Market Cap	19.21B
Revenue (ttm)	4.69B
Net Income (ttm)	508.35M
Shares Out	n/a
EPS (ttm)	17.58
PE Ratio	37.78
Forward PE	n/a
Dividend	4.60 (0.69%)
Ex-Dividend Date	Feb 18, 2025

Volume	3,557
Average Volume	20,718
Open	663.00
Previous Close	664.70
Day's Range	659.00 - 678.00
52-Week Range	544.10 - 862.60
Beta	0.53
RSI	39.57
Earnings Date	Aug 11, 2025

About Chimerix

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn c...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 634
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMRUTANJAN

Financial Performance

In 2024, Amrutanjan Health Care's revenue was 4.69 billion, an increase of 11.42% compared to the previous year's 4.21 billion. Earnings were 508.35 million, an increase of 13.03%.